ESTRO35 Programme Book

> Event reporting and learning in radiotherapy: evaluation over 4 years M. Molla Armada (Spain), D. Garcia, M. Beltran, R. Verges, C. Pacheco, R. Angles, X. Fa, J. Saez, J.M. Lobo, C. Montiel, M.T. Bordas, J. Giralt > Impact of standardised codes of practice and related audit on radiotherapy dosimetry over 20 years R. Thomas (UK), M. Bolt, G. Bass, A. Nisbet, C. Clark > Dose plan quality in the DBCG HYPO trial: an evaluation based on all treatment plans in the study M. Thomsen (Denmark), M. Berg, S. Zimmermann, C. Lutz, S. Makocki, I. Jensen, M. Hjelstuen, S. Pensold, M.B. Jensen, B. Offersen > UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus G.G. Hanna (UK), R. Patel, K. Aitken, S. Jain, K. Franks, N. Van As, A. Tree, S. Harrow, D.J. Eaton, F. McDonald, M. Ahmed, Saran, G. Webster, V. Khoo, D. Landau, M.A. Hawkins > Evaluation of pre-treatment verification for hyperthermia treatment plans D. Marder (Switzerland), N. Brändli, G. VanStam, G. Lutters > An optimal grid block design for spatially fractionated radiation therapy S. Gholami (Iran), H.A. Nedaie, F. Longo, M.R. Ay, A. S.Meigooni > Individual cases review in KROG-0806 study phase randomized trial for breast cancer patients Y.B. Kim (Republic of Korea), J. Yoon, H. Han, H. Cha, J. Choi, M. Lee, C.O. Suh > Assessment of variation in planning benchmark case for ABC-07 trial of liver SBRT D. Eaton (UK), M. Robinson, R. Patel, M. Hawkins > Initial experience with the Elekta Leksell Gamma Knife Icon system: commissioning, QA and workflow S.W. Blake (UK), L. Winch, H. Appleby > Implications of gold nanoparticles used for dose enhancement in proton radiotherapy R. Ahmad (UK), G. Royle, K. Ricketts

EP-1934

ELECTRONIC POSTERS

EP-1935

EP-1936

EP-1937

EP-1938

EP-1939

EP-1940

EP-1941

EP-1942

EP-1943

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

312